| Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial WTA Van Der Graaf, JY Blay, SP Chawla, DW Kim, B Bui-Nguyen, ... The Lancet 379 (9829), 1879-1886, 2012 | 2308 | 2012 |
| Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial I Judson, J Verweij, H Gelderblom, JT Hartmann, P Schöffski, JY Blay, ... The lancet oncology 15 (4), 415-423, 2014 | 1082 | 2014 |
| Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up ESMO/European Sarcoma Network Working Group Annals of Oncology 25, iii102-iii112, 2014 | 1045* | 2014 |
| Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ... Annals of Oncology 29, iv51-iv67, 2018 | 1022 | 2018 |
| Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ... Annals of oncology 29, iv68-iv78, 2018 | 986* | 2018 |
| Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up ESMO/European Sarcoma Network Working Group Annals of Oncology 25, iii21-iii26, 2014 | 722* | 2014 |
| Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ A Gronchi, AB Miah, AP Dei Tos, N Abecassis, J Bajpai, S Bauer, ... Annals of Oncology 32 (11), 1348-1365, 2021 | 701 | 2021 |
| Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, S Bielack, N Abecassis, HT Aro, S Bauer, R Biagini, ... Annals of Oncology 29, iv79-iv95, 2018 | 596 | 2018 |
| Cardiovascular morbidity in long-term survivors of metastatic testicular cancer MT Meinardi, JA Gietema, WTA Van der Graaf, DJ Van Veldhuisen, ... Journal of Clinical Oncology 18 (8), 1725-1732, 2000 | 566 | 2000 |
| Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are … J Verweij, A van Oosterom, JY Blay, I Judson, S Rodenhuis, ... European Journal of Cancer 39 (14), 2006-2011, 2003 | 518 | 2003 |
| The impact of parental cancer on children and the family: a review of the literature A Visser, GA Huizinga, WTA van der Graaf, HJ Hoekstra, ... Cancer treatment reviews 30 (8), 683-694, 2004 | 496 | 2004 |
| Indium-111–labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer PJ Perik, MN Lub-De Hooge, JA Gietema, WTA van der Graaf, ... Journal of clinical oncology 24 (15), 2276-2282, 2006 | 449 | 2006 |
| An update on the management of sporadic desmoid-type fibromatosis: a European consensus initiative between sarcoma PAtients EuroNet (SPAEN) and European organization for … B Kasper, C Baumgarten, J Garcia, S Bonvalot, R Haas, F Haller, ... Annals of Oncology 28 (10), 2399-2408, 2017 | 415 | 2017 |
| Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility MM De Jong, IM Nolte, GJ Te Meerman, WTA Van der Graaf, ... Journal of medical genetics 39 (4), 225-242, 2002 | 404 | 2002 |
| The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients B Alman, S Attia, C Baumgarten, C Benson, JY Blay, S Bonvalot, ... European Journal of Cancer 127, 96-107, 2020 | 401 | 2020 |
| Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, JY Blay, N Abecassis, J Bajpai, S Bauer, R Biagini, S Bielack, ... Annals of oncology 33 (1), 20-33, 2022 | 383 | 2022 |
| Mycobacterium ulcerans infection TS Van der Werf, WTA Van der Graaf, JW Tappero, K Asiedu The Lancet 354 (9183), 1013-1018, 1999 | 369 | 1999 |
| The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis E Bastiaannet, H Groen, PL Jager, DCP Cobben, WTA Van Der Graaf, ... Cancer treatment reviews 30 (1), 83-101, 2004 | 366 | 2004 |
| Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins BEC Plaat, H Hollema, WM Molenaar, GHT Broers, J Pijpe, MF Mastik, ... Journal of clinical oncology 18 (18), 3211-3220, 2000 | 346 | 2000 |
| Spinal extradural metastasis: review of current treatment options RHMA Bartels, YM van der Linden, WTA van der Graaf CA: a cancer journal for clinicians 58 (4), 245-259, 2008 | 315 | 2008 |
